Literature DB >> 5305935

Immunological responses of the rat to Mycoplasma arthritidis.

B C Cole, J F Cahill, B B Wiley, J R Ward.   

Abstract

Arthritis was produced in rats by the intravenous injection of Mycoplasma arthritidis. Metabolic inhibiting antibody and indirect hemagglutinating antibody could not be detected in the sera of arthritic or convalescent animals. Nonmurine species of mycoplasma were capable of inducing metabolic inhibiting antibody in the rat. A hypothesis based upon the possible occurrence of heterogenetic antigens common to M. arthritidis and rat tissue was brought forward to explain these findings. Complement-fixing antibody to M. arthritidis was detected 3 to 4 days after injection and subsequently rose to high levels, depending upon the severity of arthritis and number of organisms injected. Animals that had recovered from intravenous or subcutaneous inoculation with M. arthritidis were resistant to subsequent infections by the organism. Immunity could be passively transferred by the intravenous injection of convalescent serum. Adsorption of the convalescent serum with antigen greatly reduced the complement fixation titer but did not significantly alter the protective properties of the serum. The presence of complement-fixing antibody could not be related to the development of immunity. An avirulent strain of M. arthritidis and a strain previously classified as M. hominis type 2 were capable of inducing resistance to subsequent injection by virulent M. arthritidis.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5305935      PMCID: PMC315276          DOI: 10.1128/jb.98.3.930-937.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

2.  Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity.

Authors:  D ROWLEY; C R JENKIN
Journal:  Nature       Date:  1962-01-13       Impact factor: 49.962

3.  Arthritis in rats produced by pleuro-pneumonia-like organisms.

Authors:  M W PARKES; F WRIGLEY; B O'BRIEN
Journal:  Ann Rheum Dis       Date:  1951-06       Impact factor: 19.103

4.  Role of complement in immune inactivation of Mycoplasma gallisepticum.

Authors:  L F Barker; J K Patt
Journal:  J Bacteriol       Date:  1967-08       Impact factor: 3.490

5.  The evaluation of the metabolic-inhibition technique for the study of Mycoplasma gallisepticum.

Authors:  D Taylor-Robinson; D M Berry
Journal:  J Gen Microbiol       Date:  1969-01

6.  Tissue cultures and mycoplasmas.

Authors:  L Hayflick
Journal:  Tex Rep Biol Med       Date:  1965-06

7.  A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species.

Authors:  R H Purcell; D Taylor-Robinson; D C Wong; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-07       Impact factor: 4.897

8.  A comparative study on the virulence of Mycoplasma arthritidis and "Mycoplasma hominis, type 2" strains in rats.

Authors:  B C Cole; M L Miller; J R Ward
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

9.  Characterization of mycoplasma strains from cats.

Authors:  B C Cole; L Golightly; J R Ward
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

10.  Differences between Brucella antigens involved in indirect hemagglutination tests with normal and tanned red blood cells.

Authors:  R Diaz; L M Jones; D Leong; J B Wilson
Journal:  J Bacteriol       Date:  1967-09       Impact factor: 3.490

View more
  24 in total

1.  Comparison of four Mycoplasma arthritidis strains by enzyme immunoassay, metabolism inhibition, one- and two-dimensional electrophoresis, and immunoblotting.

Authors:  L R Washburn; S Hirsch
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Effect of Animal Passage on Arthritogenic and Biological Properties of Mycoplasma arthritidis.

Authors:  L Golightly-Rowland; B C Cole; J R Ward; B B Wiley
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

3.  Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

4.  Killing of mycoplasmas by the antibodies to foreign antigens acquired by the organisms from the growth medium.

Authors:  K K Sethi; H Brandis
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

5.  Protection of rats against Mycoplasma arthritidis-induced arthritis by active and passive immunizations with two surface antigens.

Authors:  L R Washburn; E J Weaver
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

6.  Characterization of the metabolism inhibition antigen of Mycoplasma arthritidis.

Authors:  L R Washburn; J R Ramsay; L K Roberts
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

7.  Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

8.  Association of lysogenic bacteriophage MAV1 with virulence of Mycoplasma arthritidis.

Authors:  L L Voelker; K E Weaver; L J Ehle; L R Washburn
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Fate of intravenously injected Mycoplasma arthritidis in rodents and effect of vaccines.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  [Factors influencing the susceptibility of mice to Mycoplasma arthritidis].

Authors:  B C Cole; J R Ward; L Golightly-Rowland
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.